Alanna A Morris1, Robert T Cole2, S Raja Laskar2, Andreas Kalogeropoulos2, J David Vega3, Andrew Smith2, Javed Butler4. 1. Division of Cardiology Department of Medicine, Emory University School of Medicine, Atlanta, Georgia; Division of Cardiology Department of Medicine, Atlanta VA Medical Center, Atlanta, Georgia. Electronic address: aamorr3@emory.edu. 2. Division of Cardiology Department of Medicine, Emory University School of Medicine, Atlanta, Georgia. 3. Division of Cardiology Department of Medicine, Emory University School of Medicine, Atlanta, Georgia; Division of Cardiology Department of Medicine, Atlanta VA Medical Center, Atlanta, Georgia. 4. Division of Cardiology Department of Medicine, Stony Brook University, Stony Brook, New York.
Abstract
BACKGROUND: Whether the routine use of continuous-flow left ventricular assist devices (LVAD) has affected gender differences in outcomes for patients listed for heart transplantation (HT) is unclear. METHODS AND RESULTS: We identified 20,468 adults (25% women) listed as status 1A or 1B for HT from 2000 to 2014. Sex differences in removal from the wait list during the first 365 days due to death or deterioration was assessed with the use of Kaplan-Meier survival analysis. Patients were stratified according to listing before (era 1) or after (era 2) Food and Drug Administration approval of the Heartmate II LVAD on April 22, 2008. Freedom from death or deterioration on the wait list was higher for men than for women (70% vs 64%; P < .001). After adjusting for risk factors, women had a higher risk of removal from the wait list at 365 days during both era 1 (hazard ratio [HR] 1.23, 95% confidence interval [CI] 1.10-1.36; P < .001) and era 2 (HR 1.15, 95% CI 1.01-1.31; P = .029). Further adjustment for LVAD use eliminated the higher risk for women in era 2 (HR 1.14, 95% CI 0.99-1.29; P = .053) and not in era 1 (HR 1.22, 95% CI 1.10-1.36; P < .001). CONCLUSIONS: The higher risk for death or deterioration in women waiting for HT has improved in the modern era.
BACKGROUND: Whether the routine use of continuous-flow left ventricular assist devices (LVAD) has affected gender differences in outcomes for patients listed for heart transplantation (HT) is unclear. METHODS AND RESULTS: We identified 20,468 adults (25% women) listed as status 1A or 1B for HT from 2000 to 2014. Sex differences in removal from the wait list during the first 365 days due to death or deterioration was assessed with the use of Kaplan-Meier survival analysis. Patients were stratified according to listing before (era 1) or after (era 2) Food and Drug Administration approval of the Heartmate II LVAD on April 22, 2008. Freedom from death or deterioration on the wait list was higher for men than for women (70% vs 64%; P < .001). After adjusting for risk factors, women had a higher risk of removal from the wait list at 365 days during both era 1 (hazard ratio [HR] 1.23, 95% confidence interval [CI] 1.10-1.36; P < .001) and era 2 (HR 1.15, 95% CI 1.01-1.31; P = .029). Further adjustment for LVAD use eliminated the higher risk for women in era 2 (HR 1.14, 95% CI 0.99-1.29; P = .053) and not in era 1 (HR 1.22, 95% CI 1.10-1.36; P < .001). CONCLUSIONS: The higher risk for death or deterioration in women waiting for HT has improved in the modern era.
Authors: Eileen M Hsich; Eugene H Blackstone; Lucy Thuita; Dennis M McNamara; Joseph G Rogers; Hemant Ishwaran; Jesse D Schold Journal: Circ Heart Fail Date: 2017-06 Impact factor: 8.790
Authors: Rebecca S Steinberg; Aditi Nayak; Celena O'Connell; Sharon Burford; Ann Pekarek; Neile Chesnut; Robert T Cole; Divya Gupta; S Raja Laskar; Kunal Bhatt; Michael Burke; Tamer Attia; Andrew Smith; J David Vega; Alanna A Morris Journal: Clin Transplant Date: 2020-03-16 Impact factor: 2.863
Authors: Khadijah Breathett; Larry A Allen; Laura Helmkamp; Kathryn Colborn; Stacie L Daugherty; Prateeti Khazanie; Richard Lindrooth; Pamela N Peterson Journal: JACC Heart Fail Date: 2017-01-18 Impact factor: 12.035
Authors: Eileen M Hsich; Eugene H Blackstone; Lucy W Thuita; Dennis M McNamara; Joseph G Rogers; Clyde W Yancy; Lee R Goldberg; Maryam Valapour; Gang Xu; Hemant Ishwaran Journal: JACC Heart Fail Date: 2020-06-10 Impact factor: 12.035
Authors: María Dolores García-Cosío; Francisco González-Vilchez; Raquel López-Vilella; Eduardo Barge-Caballero; Manuel Gómez Bueno; Manuel Martínez-Selles; Jose María Arizón; Diego Rangel Sousa; José González-Costello; Sonia Mirabet; Félix Pérez-Villa; Beatriz Díaz Molina; Gregorio Rábago; Ana Portolés Ocampo; Luis de la Fuente Galán; Iris Garrido; Juan F Delgado Journal: Front Cardiovasc Med Date: 2021-02-25
Authors: Michael A Fuery; Fouad Chouairi; Peter Natov; Jasjit Bhinder; Maya Rose Chiravuri; Lynn Wilson; Katherine A Clark; Samuel W Reinhardt; Clancy Mullan; P Elliott Miller; Robert P Davis; Joseph G Rogers; Chetan B Patel; Sounok Sen; Arnar Geirsson; Muhammad Anwer; Nihar Desai; Tariq Ahmad Journal: J Am Heart Assoc Date: 2021-11-08 Impact factor: 5.501
Authors: Alexander T Sandhu; Rebecca L Tisdale; Fatima Rodriguez; Randall S Stafford; David J Maron; Tina Hernandez-Boussard; Eldrin Lewis; Paul A Heidenreich Journal: Circ Heart Fail Date: 2021-07-27 Impact factor: 10.447